360biolabs is a contract service organisation which provides speciality expertise and laboratory services in the development of  new therapeutics, vaccines and diagnostics in a quality-assured environment based within laboratories at the Burnet Institute.

The company has particular expertise in virology, immunology and analytical chemistry, with broad assay capabilities. These include assays and biomarker endpoints for clinical trials and preclinical studies in a range of therapeutic areas including infectious diseases, inflammation and oncology.

Clients range from small biotechs to large multinational pharmaceutical companies.

360biolabs is an accredited facility with systems that comply with strict regulatory and industry standards, offering:

  • ISO / IEC 17025 and ISO / IEC 15189 accreditation in accordance with the requirements of the OECD Principles of GLP
  • ICH / FDA / EMA compliant assay validation process
  • Industry-standard studies and reports to support global regulatory submissions

World-class facilities including BSL-2 and BSL-3 laboratories secured with continuity fail-safes.

For more information: 360biolabs.com